DK0946585T3 - Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf - Google Patents

Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf

Info

Publication number
DK0946585T3
DK0946585T3 DK97952972T DK97952972T DK0946585T3 DK 0946585 T3 DK0946585 T3 DK 0946585T3 DK 97952972 T DK97952972 T DK 97952972T DK 97952972 T DK97952972 T DK 97952972T DK 0946585 T3 DK0946585 T3 DK 0946585T3
Authority
DK
Denmark
Prior art keywords
drugs
preparation
pharmaceutical compositions
compositions containing
compounds substituted
Prior art date
Application number
DK97952972T
Other languages
Danish (da)
English (en)
Inventor
Yamina Bouali
Francois Nique
Jean-Georges Teutsch
De Velde Patrick Van
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0946585T3 publication Critical patent/DK0946585T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97952972T 1996-12-23 1997-12-22 Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf DK0946585T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615829A FR2757519B1 (fr) 1996-12-23 1996-12-23 Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
PCT/FR1997/002379 WO1998028324A1 (fr) 1996-12-23 1997-12-22 Steroides substitues en position 11, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
DK0946585T3 true DK0946585T3 (da) 2002-08-05

Family

ID=9498983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952972T DK0946585T3 (da) 1996-12-23 1997-12-22 Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf

Country Status (33)

Country Link
US (3) US6207657B1 (ru)
EP (1) EP0946585B1 (ru)
JP (1) JP4376319B2 (ru)
KR (1) KR20000062288A (ru)
CN (1) CN1247541A (ru)
AP (1) AP9901567A0 (ru)
AR (1) AR010857A1 (ru)
AT (1) ATE216396T1 (ru)
AU (1) AU726350B2 (ru)
BR (1) BR9714433A (ru)
CA (1) CA2275955A1 (ru)
CZ (1) CZ227899A3 (ru)
DE (1) DE69712095T2 (ru)
DK (1) DK0946585T3 (ru)
EA (1) EA001868B1 (ru)
ES (1) ES2174329T3 (ru)
FR (1) FR2757519B1 (ru)
HR (1) HRP970711B1 (ru)
HU (1) HUP0001447A3 (ru)
ID (1) ID22627A (ru)
IL (1) IL130509A0 (ru)
NO (1) NO313333B1 (ru)
NZ (1) NZ336224A (ru)
PL (1) PL334124A1 (ru)
PT (1) PT946585E (ru)
SI (1) SI0946585T1 (ru)
SK (1) SK83099A3 (ru)
TR (1) TR199901453T2 (ru)
TW (1) TW492974B (ru)
UA (1) UA54483C2 (ru)
WO (1) WO1998028324A1 (ru)
YU (1) YU29299A (ru)
ZA (1) ZA9711324B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2780060B1 (fr) 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
DE19929715A1 (de) * 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
WO1994021667A1 (en) * 1993-03-25 1994-09-29 Iskra Industry Co., Ltd. Compound for inhibiting bone resorption and accelerating osteogenesis
DE4329867C1 (de) * 1993-09-03 1994-09-15 Siemens Ag Stromspiegel
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
FR2761992B1 (fr) * 1997-04-09 1999-06-11 Hoechst Marion Roussel Inc Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2771096B1 (fr) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
HUP0001447A3 (en) 2001-03-28
AU726350B2 (en) 2000-11-02
EP0946585A1 (fr) 1999-10-06
AU5667898A (en) 1998-07-17
NO993125D0 (no) 1999-06-23
WO1998028324A1 (fr) 1998-07-02
SI0946585T1 (en) 2002-10-31
JP4376319B2 (ja) 2009-12-02
DE69712095D1 (de) 2002-05-23
EA199900588A1 (ru) 2000-02-28
IL130509A0 (en) 2000-06-01
NZ336224A (en) 2001-02-23
US6541464B2 (en) 2003-04-01
CN1247541A (zh) 2000-03-15
HRP970711B1 (en) 2002-04-30
PL334124A1 (en) 2000-02-14
SK83099A3 (en) 2000-01-18
DE69712095T2 (de) 2002-11-14
NO313333B1 (no) 2002-09-16
PT946585E (pt) 2002-09-30
TW492974B (en) 2002-07-01
HRP970711A2 (en) 1998-10-31
HUP0001447A1 (hu) 2000-11-28
ID22627A (id) 1999-12-02
NO993125L (no) 1999-08-20
CA2275955A1 (fr) 1998-07-02
BR9714433A (pt) 2000-05-02
US6207657B1 (en) 2001-03-27
ATE216396T1 (de) 2002-05-15
EA001868B1 (ru) 2001-10-22
FR2757519A1 (fr) 1998-06-26
TR199901453T2 (xx) 1999-08-23
KR20000062288A (ko) 2000-10-25
JP2001507010A (ja) 2001-05-29
US20020198374A1 (en) 2002-12-26
US6482813B1 (en) 2002-11-19
ES2174329T3 (es) 2002-11-01
FR2757519B1 (fr) 1999-06-11
CZ227899A3 (cs) 1999-09-15
UA54483C2 (ru) 2003-03-17
AP9901567A0 (en) 1999-06-30
ZA9711324B (en) 1999-01-19
EP0946585B1 (fr) 2002-04-17
YU29299A (sh) 2001-05-28
AR010857A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
NO964700D0 (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
NO20016038L (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
HRP960558B1 (en) New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
DK0477049T3 (da) 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
NO973922L (no) Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9701194A3 (en) 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP0002037A3 (en) Hydroximic acid derivatives, use of them for producing pharmaceutical compositions suitable for inhibiting matrix metalloproteinas and pharmaceutical compositions containing the compounds
EE9800426A (et) Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
IL143577A0 (en) Piperazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid